Financial News
BioAtla, Inc. - Common Stock (NQ: BCAB )
0.3322
-0.0079
(-2.32%)
Streaming Delayed Price
Updated: 9:43 AM EST, Feb 26, 2025
Add to My Watchlist
All News about BioAtla, Inc. - Common Stock

From BioAtla, Inc.
Via GlobeNewswire

From BioAtla, Inc.
Via GlobeNewswire

Where BioAtla Stands With Analysts
May 15, 2023
Via Benzinga


Expert Ratings for BioAtla
March 24, 2023
Via Benzinga

Earnings Outlook For BioAtla
March 22, 2023
Via Benzinga

From BioAtla, Inc.
Via GlobeNewswire





BioAtla Announces Change in Executive Leadership
February 27, 2023
From BioAtla, Inc.
Via GlobeNewswire


Dow Rises Over 100 Points; Rayonier Advanced Materials Shares Plunge
January 10, 2023
Via Benzinga




From BioAtla, Inc.
Via GlobeNewswire

From BioAtla, Inc.
Via GlobeNewswire

BioAtla to Participate in the Jefferies London Healthcare Conference
November 08, 2022
From BioAtla, Inc.
Via GlobeNewswire

Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
January 05, 2023
Via Benzinga

Via Benzinga



BioAtla Announces $65 Million Underwritten Offering of its Common Stock
November 04, 2022
From BioAtla, Inc.
Via GlobeNewswire



BioAtla Reports Third Quarter 2022 Financial Results and Highlights Recent Progress
November 03, 2022
From BioAtla, Inc.
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.